BioGaia AB (Sweden) Performance

BIOG-B Stock  SEK 114.90  1.60  1.37%   
BioGaia AB has a performance score of 3 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.31, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, BioGaia AB's returns are expected to increase less than the market. However, during the bear market, the loss of holding BioGaia AB is expected to be smaller as well. BioGaia AB right now shows a risk of 1.73%. Please confirm BioGaia AB standard deviation, total risk alpha, treynor ratio, as well as the relationship between the jensen alpha and sortino ratio , to decide if BioGaia AB will be following its price patterns.

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in BioGaia AB are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, BioGaia AB is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors. ...more
Begin Period Cash Flow1.5 B
  

BioGaia AB Relative Risk vs. Return Landscape

If you would invest  11,020  in BioGaia AB on December 22, 2024 and sell it today you would earn a total of  470.00  from holding BioGaia AB or generate 4.26% return on investment over 90 days. BioGaia AB is generating 0.0854% of daily returns and assumes 1.7293% volatility on return distribution over the 90 days horizon. Simply put, 15% of stocks are less volatile than BioGaia, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days trading horizon BioGaia AB is expected to generate 2.05 times more return on investment than the market. However, the company is 2.05 times more volatile than its market benchmark. It trades about 0.05 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly -0.04 per unit of risk.

BioGaia AB Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for BioGaia AB's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as BioGaia AB, and traders can use it to determine the average amount a BioGaia AB's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0494

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskBIOG-BHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 1.73
  actual daily
15
85% of assets are more volatile

Expected Return

 0.09
  actual daily
1
99% of assets have higher returns

Risk-Adjusted Return

 0.05
  actual daily
3
97% of assets perform better
Based on monthly moving average BioGaia AB is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BioGaia AB by adding it to a well-diversified portfolio.

BioGaia AB Fundamentals Growth

BioGaia Stock prices reflect investors' perceptions of the future prospects and financial health of BioGaia AB, and BioGaia AB fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on BioGaia Stock performance.

About BioGaia AB Performance

By analyzing BioGaia AB's fundamental ratios, stakeholders can gain valuable insights into BioGaia AB's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if BioGaia AB has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if BioGaia AB has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
BioGaia AB develops, markets, and sells probiotic products with documented health benefits worldwide. BioGaia AB was founded in 1990 and is headquartered in Stockholm, Sweden. BioGaia AB operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. It employs 144 people.

Things to note about BioGaia AB performance evaluation

Checking the ongoing alerts about BioGaia AB for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for BioGaia AB help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Evaluating BioGaia AB's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate BioGaia AB's stock performance include:
  • Analyzing BioGaia AB's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether BioGaia AB's stock is overvalued or undervalued compared to its peers.
  • Examining BioGaia AB's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating BioGaia AB's management team can have a significant impact on its success or failure. Reviewing the track record and experience of BioGaia AB's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of BioGaia AB's stock. These opinions can provide insight into BioGaia AB's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating BioGaia AB's stock performance is not an exact science, and many factors can impact BioGaia AB's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for BioGaia Stock analysis

When running BioGaia AB's price analysis, check to measure BioGaia AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioGaia AB is operating at the current time. Most of BioGaia AB's value examination focuses on studying past and present price action to predict the probability of BioGaia AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioGaia AB's price. Additionally, you may evaluate how the addition of BioGaia AB to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Global Correlations
Find global opportunities by holding instruments from different markets
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals